Brookstone Capital Management »

Tg Therapeutics shares owned by Brookstone Capital Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Brookstone Capital Management from 13F filings

Historical chart of Brookstone Capital Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Brookstone Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $257k 17k 15.21
2023-12-31 $288k 17k 17.08
2023-09-30 $117k 18k 6.68
2023-06-30 $427k 17k 24.96
2023-03-31 $352k 17k 20.55
2022-12-31 $153k 14k 10.80
2022-09-30 $67k 12k 5.71

More positions owned by Brookstone Capital Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Northern Lts Fd Tr Iv Brookstone Grwth (BAMG)
Northern Lts Fd Tr Iv Brookstone Value (BAMV)
Northern Lts Fd Tr Iv Brookstone Divid (BAMD)
Microsoft Corporation (MSFT)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)

View all positions for Brookstone Capital Management

Top funds holding Tg Therapeutics

Vanguard Group
Darwin Global Management
Millennium Management
Wellington Management Company
Opaleye Management
Paradigm Biocapital Advisors
683 Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Norges Bank Investment Management
Marshall Wace
Gts Securities
Soleus Capital Management
Jane Street

View all funds holding Tg Therapeutics